The black box warnings on hormone treatments prescribed to treat menopause will be removed in an effort to encourage their use, U.S. health officials said Monday.

The Food and Drug Administration plans to remove references to risk of breast cancer, heart disease and dementia on hormone replacement therapy products used to relieve symptoms of menopause and perimenopause. These labels had leaned on "misinformation" and scared off potential patients, FDA officials said. MORE: Raynaud's syndrome can be painful and annoying, but it's usually not dangerous

"We now have a more nuanced understanding, and we want to put that fear machine in its proper context," FDA Commissioner Marty Makary told " CBS Mornings ." "... Arguably with the exception of vaccines or antibiotics, there's no medic

See Full Page